Patrick Durez

Rheumatology — Cliniques Universitaires Saint-Luc, Belgium

LeadR Profile

1 303 ScienceLeadR Reputation 1303
Network Map

Rheumatology

Subspecialties: Pulmonology - Biochemistry - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1992 - 2026

Source: PubMed

Cliniques Universitaires Saint-Luc

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 343

Citations

Citations: 14 402 1st author: 39 Last author: 65 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Spatial and functional characterization of ER stress proteins links fibroblast plasticity and proliferative processes in human osteoarthritic synovitis.
cell differentiation, stress, physiological, arthritis, heat-shock proteins, fibroblasts, cell death, synovitis
Cell Death Differ20260
Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE study.
safety, arthritis, rheumatic diseases, herpes zoster, arthritis, rheumatoid, adalimumab, therapeutics, non-responder
RMD Open20260
Autoantibody biomarkers and first-line therapy response in RA: findings from the CAP48 cohort.
biomarkers, therapeutics
RMD Open20260
Immune checkpoint-induced arthritis: a comprehensive single-cohort descriptive analysis from clinical evaluation to histology.
arthritis, histology
Front Med (Lausanne)20250
The relationship between clinical disease activity, synovial inflammatory profile, and treatment response in rheumatoid arthritis.
arthritis, arthritis, rheumatoid, therapeutics, tissues
Lancet Rheumatol20250

Clinical Studies 33

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 7 Study Director: 1

By phase:

Phase 3 10
Phase 2 9
N/A 7
Phase 4 6

By status:

Completed 27
Recruiting 2
Unknown 2
Active not recruiting 1

By type:

Interventional 30
Observational 2

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 1
multicentric5to9 2
multicentricup10 20

Main Topics

Cohort/Consortium Investigators 6

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity guided Dose Reduction in Patients With Rheumatoid Arthritis
NCT06003283 — arthritis, rituximab, arthritis, rheumatoid, drug tapering, therapeutics
Phase 4Recruiting2024

LeadR Networks

Main global connection map